Epstein-barr Virus Related Lymphoproliferative Disorder
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus Related Lymphoproliferative Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants [Phase 1]
Phase 1 trial of the BZLF1 peptide vaccine OSU-2131 with QS-21 to prevent Epstein-Barr virus–related cancers in patients awaiting solid orga…